2020
DOI: 10.1016/j.ajps.2019.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 32 publications
0
3
0
1
Order By: Relevance
“…The osmolarity requirements for injection preparations fall in the range of 200-300 m Osmol. A high osmolarity level can potentially lead to pain and burning sensations during injection [16] and the specific value depends on the number of moles in the chemical compound. Based on the results, MK fell in the acceptable range for injection preparation requirements.…”
Section: Osmolarity Ph and Viscositymentioning
confidence: 99%
See 1 more Smart Citation
“…The osmolarity requirements for injection preparations fall in the range of 200-300 m Osmol. A high osmolarity level can potentially lead to pain and burning sensations during injection [16] and the specific value depends on the number of moles in the chemical compound. Based on the results, MK fell in the acceptable range for injection preparation requirements.…”
Section: Osmolarity Ph and Viscositymentioning
confidence: 99%
“…It is an excellent carrier for hydrophilic and hydrophobic drugs in parenteral formulations due to the superior stability compared to nanoemulsions and those with a size below 50 nm [11,15]. This compound can be used as carrier for parenteral vaccines to enhance the cellular immune response to viruses [16]. Compared to other colloidal carriers, microemulsion can effectively serve as drug delivery system for hydrophobic drugs due to the unique characteristics, including thermodynamic stability, tiny droplet size, and ease of fabrication attributed to the role of the oil component [17].…”
Section: Introductionmentioning
confidence: 99%
“…Si bien, generalmente, se prefiere el uso de emulsionantes no iónicos, también es posible realizar emulsiones nanométricas con emulsionantes iónicos con bajos efectos celulares [79]. Existen diversos métodos para comprobar la seguridad de estos preparados y que se corresponden con su potencial uso.…”
Section: Farmacéutica Y Biomedicinaunclassified
“…They offer several advantages, including improved drug solubility, increased bioavailability of poorly water-soluble drugs, and enhanced chemical stability [ 16 , 21 , 22 , 23 ]. The intensive utilization of MEs spans various administration routes, including oral [ 24 , 25 , 26 , 27 ], topical [ 28 , 29 , 30 , 31 ], and parenteral [ 32 , 33 , 34 , 35 ], establishing them as promising carrier systems for delivering a broad spectrum of active ingredients, including drugs that are either water-soluble or poorly water-soluble [ 11 , 36 ].…”
Section: Introductionmentioning
confidence: 99%